01—Abstract
Summary
Summary of the 8-K filed February 4, 2026. Cited figures are marked; the original filing is the authoritative source.
IDEX Corporation (NYSE: IEX) furnished an 8-K on February 4, 2026, attaching a press release reporting fourth-quarter and full-year 2025 results.
For the full year, net sales were $3,457.5 milliona, up 6% on a reported basis and 1% organically, with reported diluted EPS of $6.41 (down from $6.64) and adjusted diluted EPS of $7.95 (up from $7.89). Net income attributable to IDEX was $483.2 million versus $505.0 million in 2024, reflecting higher depreciation, amortization, restructuring costs, interest expense and taxes. The company cited a higher effective tax rate tied to 2025 legislation.
Fourth-quarter net sales were $899.1 millionb, up 4% reported and 1% organic, and orders reached a record $979.2 million, up 20% reported and 16% organically, driven mostly by the HST segment. Management attributed HST order growth to AI-related projects, including data center power and semiconductor applications, while describing FMT and FSDP as operating in a challenging demand environment. Cash flow from operations for the year was $680.4 million and free cash flow was $616.8 million, with $247.8 million used for share repurchases.
Free cash flow conversion was 103%. For 2026, IDEX projects full-year organic sales growth of 1% to 2% and adjusted diluted EPS of $8.15 to $8.35c, and first-quarter organic sales growth of approximately 1% with adjusted diluted EPS of $1.73 to $1.78. The company does not reconcile these forward-looking non-GAAP measures to GAAP because the timing and magnitude of certain items cannot be reasonably estimated.
02—Key points
Key Highlights
- Fourth-quarter orders were a record $979.2 million, up 20% reported and 16% organically, led by the HST segment.
- Full-year 2025 net sales were a record $3,457.5 million, up 6% reported and 1% organically.
- Reported diluted EPS fell to $6.41 from $6.64, while adjusted diluted EPS rose to $7.95 from $7.89.
- Full-year operating cash flow was $680.4 million and free cash flow was $616.8 million, with free cash flow conversion of 103%.
- IDEX repurchased $247.8 million of common stock in 2025, including $75.0 million in the fourth quarter.
- 2026 guidance calls for full-year organic sales growth of 1% to 2% and adjusted diluted EPS of $8.15 to $8.35.
- The effective tax rate rose due to 2025 legislation that reduced tax benefits on certain foreign-sourced income and increased state income taxes.
03—Questions
Frequently Asked Questions
How did IDEX perform in fourth quarter 2025?
Net sales were $899.1 million, up 4% reported and 1% organically. Orders were a record $979.2 million, up 20% reported. Reported diluted EPS was $1.71 and adjusted diluted EPS was $2.10, up 3%.
What drove the growth in HST segment orders?
Management attributed the fourth-quarter order growth in the HST segment to increasing demand for AI-related projects, including data center power solutions and semiconductor applications.
What is IDEX's 2026 outlook?
IDEX projects full-year 2026 organic sales growth of 1% to 2% and adjusted diluted EPS of $8.15 to $8.35. For the first quarter, it projects organic sales growth of approximately 1% and adjusted diluted EPS of $1.73 to $1.78.
Why did reported diluted EPS decline in 2025?
Reported diluted EPS decreased to $6.41 from $6.64, as higher operating results were more than offset by higher depreciation, amortization, restructuring costs, interest expense and taxes.
How much did IDEX return to shareholders in 2025?
IDEX used $247.8 million for share repurchases during 2025 and paid $212.6 million in cash dividends.
04—Continue